CLASS II ONGOING Drug recall · Reported 25 Jun 2025 · FDA Enforcement Report

Gentamicin Injection, USP, (Pediatric), 20 mg recalled by Eugia US

Eugia US is recalling Gentamicin Injection, USP, (Pediatric), 20 mg per (10 mg per mL*) Single-Dose Vial, distributed nationwide in the US. The recall was initiated on 29 May 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesBatch 3GT23006, 3GT23007, 3GT23008, Exp Date: November, 30, 2025
NDC55150-401
Quantity recalled48,000 vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0472-2025
FDA event ID
96976
Recalling firm
Eugia US, East Windsor, NJ
Manufacturer
Eugia US LLC
Classification
Class II
Status
Ongoing
Recall initiated
29 May 2025
FDA classified
18 Jun 2025
Reported
25 Jun 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

29 May 2025Recall initiated by company
18 Jun 2025Classified by FDA+20 days
25 Jun 2025Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Stability Specifications: Out of specification results for the Color Absorbance test during 12 Month sample analysis.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Gentamicin Injection, USP, (PEDIATRIC), 20 mg per 2 mL (10 mg per mL*), 2 mL Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ, 08520 Vial- NDC 55150-401-01, Carton NDC 55150-401-25

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Why was it recalled?

Failed Stability Specifications: Out of specification results for the Color Absorbance test during 12 Month sample analysis.

Which lots are affected?

Batch 3GT23006, 3GT23007, 3GT23008, Exp Date: November, 30, 2025

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Eugia US

All 17

Other Gentamicin recalls

All 27